200 related articles for article (PubMed ID: 20543713)
1. Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?
Chapman N; Chen CY; Fujita T; Hobbs FD; Kim SJ; Staessen JA; Tanomsup S; Wang JG; Williams B
J Hypertens; 2010 Sep; 28(9):1796-803. PubMed ID: 20543713
[TBL] [Abstract][Full Text] [Related]
2. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.
Chapman N; Chang CL; Dahlöf B; Sever PS; Wedel H; Poulter NR;
Circulation; 2008 Jul; 118(1):42-8. PubMed ID: 18559700
[TBL] [Abstract][Full Text] [Related]
3. Doxazosin in the current treatment of hypertension.
Wykretowicz A; Guzik P; Wysocki H
Expert Opin Pharmacother; 2008 Mar; 9(4):625-33. PubMed ID: 18312163
[TBL] [Abstract][Full Text] [Related]
4. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
6. Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study.
de Alvaro F; Hernández-Presa MA;
J Cardiovasc Pharmacol; 2006 Feb; 47(2):271-6. PubMed ID: 16495766
[TBL] [Abstract][Full Text] [Related]
7. Clinical ease of using doxazosin in BPH patients with and without hypertension.
Steers WD; Kirby RS
Prostate Cancer Prostatic Dis; 2005; 8(2):152-7. PubMed ID: 15711605
[TBL] [Abstract][Full Text] [Related]
8. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
Ceral J; Solar M
Blood Press; 2009; 18(1-2):74-7. PubMed ID: 19353415
[TBL] [Abstract][Full Text] [Related]
9. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension].
Hoogenberg K; van der Tuin J
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2099-100. PubMed ID: 12448967
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic controversies in hypertension.
Messerli FH; Grossman E
Semin Nephrol; 2005 Jul; 25(4):227-35. PubMed ID: 16202695
[TBL] [Abstract][Full Text] [Related]
11. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
Calvo C; Gil-Extremera B; Gomez-Fernández P; Masramon X; Pueyo C; Armada B
Int J Cardiol; 2005 May; 101(1):97-104. PubMed ID: 15860390
[TBL] [Abstract][Full Text] [Related]
12. The role of alpha 1-blockers in combination therapy for hypertension.
Zusman RM
Int J Clin Pract; 2000; 54(1):36-40. PubMed ID: 10750258
[TBL] [Abstract][Full Text] [Related]
13. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
14. Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system.
Guzik P; Wykretowicz A; Krauze T; Piskorski J; Adamska K; Milewska A; Wesseling KH; Wysocki H
Hypertens Res; 2008 Mar; 31(3):443-53. PubMed ID: 18497463
[TBL] [Abstract][Full Text] [Related]
15. Should patients with benign prostatic hypertrophy stop taking doxazosin in the light of the ALLHAT study?
Cheng TO
Int J Cardiol; 2006 Feb; 107(2):275-6. PubMed ID: 16412808
[No Abstract] [Full Text] [Related]
16. Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization.
Xie F; Petitti DB; Chen W
Am J Hypertens; 2005 Apr; 18(4 Pt 1):464-9. PubMed ID: 15831354
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral antihypertensive agents on blood lipid levels.
Leren P
Clin Ther; 1986; 8(3):309-19. PubMed ID: 2872961
[TBL] [Abstract][Full Text] [Related]
18. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
19. [Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].
Düsing R
Dtsch Med Wochenschr; 2003 Jan; 128(5):214-6. PubMed ID: 12557115
[No Abstract] [Full Text] [Related]
20. [Choice of antihypertensive agent--insignificant role of doxazosin (Alfadil). How are evidence-based recommendations implemented?].
Gustafsson LL
Lakartidningen; 2004 Jan; 101(3):228-9. PubMed ID: 14763097
[No Abstract] [Full Text] [Related]
[Next] [New Search]
